검색결과 : 6건
| No. | Article |
|---|---|
| 1 |
Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease Griffett K, Burris TP Biochemical and Biophysical Research Communications, 479(3), 424, 2016 |
| 2 |
Suppression of atherosclerosis by synthetic REV-ERB agonist Sitaula S, Billon C, Kamenecka TM, Solt LA, Burris TP Biochemical and Biophysical Research Communications, 460(3), 566, 2015 |
| 3 |
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists Solt LA, Wang YJ, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, Shin Y, Liu J, Cameron MD, Noel R, Yoo SH, Takahashi JS, Butler AA, Kamenecka TM, Burris TP Nature, 485(7396), 62, 2012 |
| 4 |
Suppression of T(H)17 differentiation and autoimmunity by a synthetic ROR ligand Solt LA, Kumar N, Nuhant P, Wang YJ, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovic D, Schurer SC, Xu JH, Wagoner G, Drew PD, Griffin PR, Burris TP Nature, 472(7344), 491, 2011 |
| 5 |
Relationship between circadian oscillations of Rev-erb alpha expression and intracellular levels of its ligand, heme Rogers PM, Ying L, Burris TP Biochemical and Biophysical Research Communications, 368(4), 955, 2008 |
| 6 |
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor Savkur RS, Bramlett KS, Michael LF, Burris TP Biochemical and Biophysical Research Communications, 329(1), 391, 2005 |